Figure 2.
Doxorubicin (DOX)-encapsulated lipoic acid-crosslinked hyaluronic acid nanoparticles (LACHA) for the treatment of CD44 over-expressed hematologic malignancy. Reproduced from Ref. [37].
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.